117 related articles for article (PubMed ID: 3613622)
1. Effect of increasing volume of cardioplegic solution on postischemic myocardial recovery.
Saydjari R; Asimakis G; Conti VR
J Thorac Cardiovasc Surg; 1987 Aug; 94(2):234-40. PubMed ID: 3613622
[TBL] [Abstract][Full Text] [Related]
2. Effects of potassium cardioplegia on high-energy phosphate kinetics during circulatory arrest with deep hypothermia in the newborn piglet heart.
Clark BJ; Woodford EJ; Malec EJ; Norwood CR; Pigott JD; Norwood WI
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):342-9. PubMed ID: 1992245
[TBL] [Abstract][Full Text] [Related]
3. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
4. Protection of the immature heart. Temperature-dependent beneficial or detrimental effects of multidose crystalloid cardioplegia in the neonatal rabbit heart.
Kempsford RD; Hearse DJ
J Thorac Cardiovasc Surg; 1990 Feb; 99(2):269-79. PubMed ID: 2299864
[TBL] [Abstract][Full Text] [Related]
5. New solution for prolonged myocardial preservation for transplantation.
Schwalb H; Grinberg L; Yaroslavsky-Houminer E; Lazarovici G; Von Oppell U; Worthington M; Merin G; Borman JB
J Heart Lung Transplant; 1998 Feb; 17(2):222-9. PubMed ID: 9513861
[TBL] [Abstract][Full Text] [Related]
6. Studies of controlled reperfusion after ischemia. XX. Reperfusate composition: detrimental effects of initial asanguineous cardioplegic washout after acute coronary occlusion.
Acar C; Partington MT; Buckberg GD
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):294-302. PubMed ID: 1992240
[TBL] [Abstract][Full Text] [Related]
7. Oxygenation of cardioplegic solutions. Potential for the calcium paradox.
Hendren WG; Geffin GA; Love TR; Titus JS; Redonnett BE; O'Keefe DD; Daggett WM
J Thorac Cardiovasc Surg; 1987 Oct; 94(4):614-25. PubMed ID: 3116349
[TBL] [Abstract][Full Text] [Related]
8. Augmenting intracellular adenosine improves myocardial recovery.
Bolling SF; Bies LE; Bove EL; Gallagher KP
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):469-74. PubMed ID: 2308364
[TBL] [Abstract][Full Text] [Related]
9. Different effects of cardioplegic solution HTK during single or intermittent administration.
Gebhard MM; Preusse CJ; Schnabel PA; Bretschneider HJ
Thorac Cardiovasc Surg; 1984 Oct; 32(5):271-6. PubMed ID: 6083614
[TBL] [Abstract][Full Text] [Related]
10. Benefits of glucose and oxygen in multidose cold cardioplegia.
Doherty NE; Turocy JF; Geffin GA; O'Keefe DD; Titus JS; Daggett WM
J Thorac Cardiovasc Surg; 1992 Feb; 103(2):219-29. PubMed ID: 1735987
[TBL] [Abstract][Full Text] [Related]
11. Optimal intraoperative protection of myocardium distal to coronary stenoses.
Silverman NA; Schmitt G; Levitsky S; Feinberg H
J Thorac Cardiovasc Surg; 1984 Sep; 88(3):424-31. PubMed ID: 6433111
[TBL] [Abstract][Full Text] [Related]
12. Benefits of normothermic induction of blood cardioplegia in energy-depleted hearts, with maintenance of arrest by multidose cold blood cardioplegic infusions.
Rosenkranz ER; Vinten-Johansen J; Buckberg GD; Okamoto F; Edwards H; Bugyi H
J Thorac Cardiovasc Surg; 1982 Nov; 84(5):667-77. PubMed ID: 7132406
[TBL] [Abstract][Full Text] [Related]
13. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
14. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
15. Prevention of reperfusional damage from ischemic myocardium.
Kao RL; Magovern GJ
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):106-14. PubMed ID: 3941553
[TBL] [Abstract][Full Text] [Related]
16. Verapamil cardioplegia: improved myocardial preservation during global ischemia.
Balderman SC; Chan AK; Gage AA
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):57-66. PubMed ID: 6738103
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of crystalloid cardioplegic solutions in patients undergoing myocardial revascularization. Effect of infusion route and regional wall motion on preservation of adenine nucleotide stores.
Silverman NA; Wright R; Levitsky S; Schmitt G; Feinberg H
J Thorac Cardiovasc Surg; 1985 Jan; 89(1):90-6. PubMed ID: 3965820
[TBL] [Abstract][Full Text] [Related]
18. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
19. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery.
Sloots KL; Vinten-Johansen J; Dobson GP
J Thorac Cardiovasc Surg; 2007 May; 133(5):1171-8. PubMed ID: 17467425
[TBL] [Abstract][Full Text] [Related]
20. Reduction of postischemic myocardial dysfunction by substrate repletion during reperfusion.
Haas GS; DeBoer LW; O'Keefe DD; Bodenhamer RM; Geffin GA; Drop LJ; Teplick RS; Daggett WM
Circulation; 1984 Sep; 70(3 Pt 2):I65-74. PubMed ID: 6430593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
